- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Recommending Cannabis in North Carolina
The law applies to clinicians that are state licensed and certified neurologists affiliated with a state-licensed hospital. On a case-by-case basis, neurologists may recommend or approve the use of non-psychoactive hemp extracts acquired by a registered caregiver from another jurisdiction for the treatment of patients that have not responded to three or more treatment options overseen by the neurologist. Under North Carolina law, neurologists meeting these criteria are exempt from all criminal and civil penalties related to recommending the use of cannabis extracts.
In order to register with the North Carolina Department of Health and Human Services (“DHHS”), the patient’s caregiver will need a written statement from the neurologist stating:
- the patient has been examined and is under the neurologist’s care,
- the patient suffers from intractable epilepsy (epilepsy that has not responded to three or more treatments), and
- the patient may benefit from treatment with hemp extract.
The neurologist’s name, address, and hospital affiliation must be provided to DHHS by the registering caregiver, and DHHS is required to treat this information as confidential.
- Must be board certified in neurology
- Must be licensed to practice medicine in North Carolina
- Must be affiliated with a state-licensed hospital
- Must have recommended three or more treatment options that the patient did not respond to
- Must provide the written statement described above to the patient’s caregiver